• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ABBOTT PRISM HTLV-I/HTLV-II; HTLV-I/ HTLV-II ANTIBODIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ABBOTT PRISM HTLV-I/HTLV-II; HTLV-I/ HTLV-II ANTIBODIES Back to Search Results
Catalog Number 06A53-48
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/08/2019
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 6a53 that has a similar product distributed in the us, list number 6e50.
 
Event Description
The customer reported false reactive prism htlv-i/ii results on 7 donor samples.The customer provided data for 7 repeat reactive donors, and they were confirmed negative on alinity.There was no reported impact to donor management.
 
Manufacturer Narrative
On may 30, 2019, the lot number of the suspect medical device was provided and updated from unknown to 94091li00.
 
Manufacturer Narrative
Review of complaint activity determined there was normal complaint activity for the prism htlv-i/htlv-ii reagent, lot 94091li00.Tracking and trending report review determined there are no related adverse or non- statistical trends.The performance of the likely cause lot was investigated, and no issues were identified.Using customer field data, the initial reactive rate (irr), repeat reactive rate (rrr), and specificity for lot 94091li00 were evaluated.The irr, rrr, and specificity were all determined to be within package insert specifications.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the investigation, no systemic issue or deficiency was identified for the prism htlv-i/htlv-ii reagent, lot 94091li00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABBOTT PRISM HTLV-I/HTLV-II
Type of Device
HTLV-I/ HTLV-II ANTIBODIES
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key8654018
MDR Text Key146510728
Report Number1415939-2019-00035
Device Sequence Number1
Product Code MTP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 07/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/30/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/11/2020
Device Catalogue Number06A53-48
Device Lot Number94091LI00
Was Device Available for Evaluation? Yes
Date Manufacturer Received06/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PRISM, LIST 06A36-04, SERIAL (B)(4); PRISM, LIST 06A36-04, SERIAL (B)(4); PRISM, LIST 06A36-04, SERIAL (B)(4); PRISM, LIST 06A36-04, SERIAL (B)(4)
-
-